Immunic, Inc. (IMUX)
16.80
+0.34
(+2.07%)
USD |
NASDAQ |
Aug 25, 10:59
Immunic 1 Year Total Returns (Daily) : 73.26% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 73.26% |
| August 21, 2026 | 74.62% |
| August 20, 2026 | 75.00% |
| August 19, 2026 | 80.25% |
| August 18, 2026 | 72.71% |
| August 17, 2026 | 77.83% |
| August 14, 2026 | 75.23% |
| August 13, 2026 | 99.93% |
| August 12, 2026 | 86.93% |
| August 11, 2026 | 82.33% |
| August 10, 2026 | 61.68% |
| August 07, 2026 | 58.48% |
| August 06, 2026 | 48.46% |
| August 05, 2026 | 42.80% |
| August 04, 2026 | 43.63% |
| August 03, 2026 | 51.37% |
| July 31, 2026 | 48.60% |
| July 30, 2026 | 45.50% |
| July 29, 2026 | 33.26% |
| July 28, 2026 | 23.52% |
| July 27, 2026 | 23.30% |
| July 24, 2026 | 25.14% |
| July 23, 2026 | 43.23% |
| July 22, 2026 | 61.41% |
| July 21, 2026 | 62.62% |
| Date | Value |
|---|---|
| July 20, 2026 | 55.60% |
| July 17, 2026 | 63.01% |
| July 16, 2026 | 67.78% |
| July 15, 2026 | 81.25% |
| July 14, 2026 | 74.88% |
| July 13, 2026 | 76.36% |
| July 10, 2026 | 76.30% |
| July 09, 2026 | 83.42% |
| July 08, 2026 | 78.12% |
| July 07, 2026 | 100.8% |
| July 06, 2026 | 104.3% |
| July 02, 2026 | 107.6% |
| July 01, 2026 | 114.5% |
| June 30, 2026 | 120.4% |
| June 29, 2026 | 120.1% |
| June 26, 2026 | 115.4% |
| June 25, 2026 | 114.9% |
| June 24, 2026 | 107.8% |
| June 23, 2026 | 112.9% |
| June 22, 2026 | 104.9% |
| June 18, 2026 | 90.25% |
| June 17, 2026 | 85.02% |
| June 16, 2026 | 67.09% |
| June 15, 2026 | 74.06% |
| June 12, 2026 | 64.24% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Sionna Therapeutics, Inc. | -77.08% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |